Skip to main content
. 2019 Dec 15;11(12):683. doi: 10.3390/pharmaceutics11120683

Figure 4.

Figure 4

(A) Binding ability of 9R-GNS, 9R/DG-GNS, PTX-TSL-(9R/DG-GNS) and siCOX-2 mixtures at different molar ratios (1:0, 1:1, 1:5, 1:10, 1:20, 1:40 & 1:60). (B) Release curves of PTX-TSL (37 °C and 43 °C) and PTX-TSL-siCOX-2(9R/DG-GNS) (37 °C and 43 °C) (n = 3). (C) Cytotoxicity analysis of GNS, 9R-GNS, 9R/DG-GNS and TSL-(9R/DG-GNS) in HUVECs at different concentrations. Data represent the mean ± SD (n = 3).